Report Categories Report Categories

Report Categories

industry Category

All

Total: 2 records, 1 pages

Global Anti-amyloid Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 27 Oct 2024

date Pharma & Healthcare

new_biaoQian Anti-amyloid Therapy

Anti-amyloid therapy refers to a treatment approach aimed at addressing Alzheimer's disease by targeting and reducing the accumulation of amyloid-beta plaques in the brain. These therapies are designed to modify the disease's progression rather than merely alleviate symptoms. By utilizing agents that bind to amyloid-beta or promote its clearance, anti-amyloid therapies seek to improve cognitive function and slow neurodegeneration in affected individuals. Prominent examples include donanemab and lecanemab, which have been used to treat early stages of Alzheimer’s.

USD3480.00

Add To Cart

Add To Cart

Global Anti-amyloid Therapy Supply, Demand and Key Producers, 2024-2030

date 27 Oct 2024

date Pharma & Healthcare

new_biaoQian Anti-amyloid Therapy

Anti-amyloid therapy refers to a treatment approach aimed at addressing Alzheimer's disease by targeting and reducing the accumulation of amyloid-beta plaques in the brain. These therapies are designed to modify the disease's progression rather than merely alleviate symptoms. By utilizing agents that bind to amyloid-beta or promote its clearance, anti-amyloid therapies seek to improve cognitive function and slow neurodegeneration in affected individuals. Prominent examples include donanemab and lecanemab, which have been used to treat early stages of Alzheimer’s.

USD4480.00

Add To Cart

Add To Cart

industry 27 Oct 2024

industry Pharma & Healthcare

new_biaoQian Anti-amyloid Therapy

Anti-amyloid therapy refers to a treatment approach aimed at addressing Alzheimer's disease by targeting and reducing the accumulation of amyloid-beta plaques in the brain. These therapies are designed to modify the disease's progression rather than merely alleviate symptoms. By utilizing agents that bind to amyloid-beta or promote its clearance, anti-amyloid therapies seek to improve cognitive function and slow neurodegeneration in affected individuals. Prominent examples include donanemab and lecanemab, which have been used to treat early stages of Alzheimer’s.

USD3480.00

addToCart

Add To Cart

industry 27 Oct 2024

industry Pharma & Healthcare

new_biaoQian Anti-amyloid Therapy

Anti-amyloid therapy refers to a treatment approach aimed at addressing Alzheimer's disease by targeting and reducing the accumulation of amyloid-beta plaques in the brain. These therapies are designed to modify the disease's progression rather than merely alleviate symptoms. By utilizing agents that bind to amyloid-beta or promote its clearance, anti-amyloid therapies seek to improve cognitive function and slow neurodegeneration in affected individuals. Prominent examples include donanemab and lecanemab, which have been used to treat early stages of Alzheimer’s.

USD4480.00

addToCart

Add To Cart